(NECB) Northeast Community Bancorp - Overview
Stock: Deposits, Loans, Securities, Insurance, Annuities
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.59% |
| Yield on Cost 5y | 11.03% |
| Yield CAGR 5y | 45.84% |
| Payout Consistency | 93.5% |
| Payout Ratio | 19.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 29.7% |
| Relative Tail Risk | -5.22% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.11 |
| Alpha | -11.08 |
| Character TTM | |
|---|---|
| Beta | 0.749 |
| Beta Downside | 0.894 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.54% |
| CAGR/Max DD | 0.58 |
Description: NECB Northeast Community Bancorp December 31, 2025
Northeast Community Bancorp, Inc. (NASDAQ:NECB) is the holding company for NorthEast Community Bank, a regional lender that serves individuals and businesses across New York and Massachusetts. The bank’s product suite includes a full range of deposit accounts-checking, money-market, savings, demand, and certificates of deposit-as well as construction, commercial-industrial, multifamily, mixed-use, and consumer loan portfolios.
Beyond traditional lending, NECB invests heavily in liquid assets such as U.S. Treasury securities, municipal bonds, deposits at the Federal Home Loan Bank of New York, and agency securities. The institution also offers ancillary financial products, notably life-insurance policies and fixed-rate annuities, to diversify non-interest income.
Its branch footprint comprises full-service locations in Bronx, Orange, Rockland, and Sullivan Counties (NY) and in Essex, Middlesex, and Norfolk Counties (MA), supplemented by loan production offices in White Plains, New City (NY), Danvers (MA), and additional points in the region. Founded in 1934, the firm is headquartered in White Plains, New York.
Key recent metrics (Q2 2025) show a net interest margin of 3.2%, a loan-to-deposit ratio of 78%, and a 5% year-over-year increase in deposits-indicating solid balance-sheet growth despite a tightening regional-bank environment. The bank’s exposure to commercial-real-estate loans in the New York metro area remains a material risk factor, especially as higher Fed rates pressure property valuations.
For a deeper quantitative assessment, you may want to explore NECB’s metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 44.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.10 > 1.0 |
| NWC/Revenue: -158.6% < 20% (prev -983.0%; Δ 824.4% < -1%) |
| CFO/TA 0.02 > 3% & CFO 50.9m > Net Income 44.4m |
| Net Debt (-10.5m) to EBITDA (63.1m): -0.17 < 3 |
| Current Ratio: 0.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (13.7m) vs 12m ago 0.65% < -2% |
| Gross Margin: 65.91% > 18% (prev 0.64%; Δ 6527 % > 0.5%) |
| Asset Turnover: 7.68% > 50% (prev 7.99%; Δ -0.32% > 0%) |
| Interest Coverage Ratio: 0.87 > 6 (EBITDA TTM 63.1m / Interest Expense TTM 53.4m) |
Altman Z'' -0.10
| A: -0.12 (Total Current Assets 24.0m - Total Current Liabilities 271.9m) / Total Assets 2.06b |
| B: 0.12 (Retained Earnings 245.0m / Total Assets 2.06b) |
| C: 0.02 (EBIT TTM 46.7m / Avg Total Assets 2.04b) |
| D: 0.14 (Book Value of Equity 245.3m / Total Liabilities 1.71b) |
| Altman-Z'' Score: -0.10 = B |
Beneish M -3.11
| DSRI: 0.93 (Receivables 12.2m/13.5m, Revenue 156.3m/160.6m) |
| GMI: 0.97 (GM 65.91% / 63.91%) |
| AQI: 1.04 (AQ_t 0.97 / AQ_t-1 0.94) |
| SGI: 0.97 (Revenue 156.3m / 160.6m) |
| TATA: -0.00 (NI 44.4m - CFO 50.9m) / TA 2.06b) |
| Beneish M-Score: -3.11 (Cap -4..+1) = AA |
What is the price of NECB shares?
Over the past week, the price has changed by +6.12%, over one month by +8.29%, over three months by +23.41% and over the past year by +4.83%.
Is NECB a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NECB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 25.5 | 4.3% |
| Analysts Target Price | 25.5 | 4.3% |
| ValueRay Target Price | 29.5 | 20.5% |
NECB Fundamental Data Overview January 31, 2026
P/S = 3.0135
P/B = 0.9081
Revenue TTM = 156.3m USD
EBIT TTM = 46.7m USD
EBITDA TTM = 63.1m USD
Long Term Debt = 170.0m USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 80.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -10.5m USD (from netDebt column, last quarter)
Enterprise Value = 384.4m USD (316.2m + Debt 80.0m - CCE 11.8m)
Interest Coverage Ratio = 0.87 (Ebit TTM 46.7m / Interest Expense TTM 53.4m)
EV/FCF = 7.82x (Enterprise Value 384.4m / FCF TTM 49.1m)
FCF Yield = 12.78% (FCF TTM 49.1m / Enterprise Value 384.4m)
FCF Margin = 31.43% (FCF TTM 49.1m / Revenue TTM 156.3m)
Net Margin = 28.41% (Net Income TTM 44.4m / Revenue TTM 156.3m)
Gross Margin = 65.91% ((Revenue TTM 156.3m - Cost of Revenue TTM 53.3m) / Revenue TTM)
Gross Margin QoQ = 67.39% (prev 66.23%)
Tobins Q-Ratio = 0.19 (Enterprise Value 384.4m / Total Assets 2.06b)
Interest Expense / Debt = 16.41% (Interest Expense 13.1m / Debt 80.0m)
Taxrate = 30.65% (4.78m / 15.6m)
NOPAT = 32.4m (EBIT 46.7m * (1 - 30.65%))
Current Ratio = 0.09 (Total Current Assets 24.0m / Total Current Liabilities 271.9m)
Debt / Equity = 0.23 (Debt 80.0m / totalStockholderEquity, last quarter 351.7m)
Debt / EBITDA = -0.17 (Net Debt -10.5m / EBITDA 63.1m)
Debt / FCF = -0.21 (Net Debt -10.5m / FCF TTM 49.1m)
Total Stockholder Equity = 339.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.18% (Net Income 44.4m / Total Assets 2.06b)
RoE = 13.07% (Net Income TTM 44.4m / Total Stockholder Equity 339.9m)
RoCE = 9.15% (EBIT 46.7m / Capital Employed (Equity 339.9m + L.T.Debt 170.0m))
RoIC = 6.57% (NOPAT 32.4m / Invested Capital 492.9m)
WACC = 9.23% (E(316.2m)/V(396.2m) * Re(8.68%) + D(80.0m)/V(396.2m) * Rd(16.41%) * (1-Tc(0.31)))
Discount Rate = 8.68% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -3.82%
[DCF Debug] Terminal Value 77.38% ; FCFF base≈49.4m ; Y1≈60.9m ; Y5≈103.8m
Fair Price DCF = 104.8 (EV 1.40b - Net Debt -10.5m = Equity 1.41b / Shares 13.5m; r=9.23% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 74.70 | EPS CAGR: 33.15% | SUE: -0.65 | # QB: 0
Revenue Correlation: 82.29 | Revenue CAGR: 33.37% | SUE: 1.24 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.79 | Chg30d=-0.010 | Revisions Net=+1 | Analysts=1
EPS current Year (2026-12-31): EPS=3.39 | Chg30d=+0.020 | Revisions Net=+1 | Growth EPS=+5.2% | Growth Revenue=+8.3%
EPS next Year (2027-12-31): EPS=3.73 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+10.0% | Growth Revenue=+11.9%